Barriers affecting the adoption of point-of-care technologies used in chest pain diagnosis within the UK National Health Service: Part 2-manufacturer pricing and reimbursement policy issues

Point of Care

Volumn 9, Issue 2, 2010, Pages 80-90

  FitzGibbon, Francis ^a   Huckle, David ^b   Meenan, Brian J ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b Adams Business Associates   (United Kingdom)

Author keywords

Cardiac markers; Chest pain; Emergency department; NHS Pathology tariff; Point of care testing (POCT); Procurement options; Reimbursement; Test panel pricing policy

Indexed keywords

EID: 77953098816     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e3181d9d895     Document Type: Article

References (72)

1. HMSO. The NHS Plan. NHS Plan Web site. July 1, 2000. Available at: http://www.nhsia.nhs.uk/nhsplan/nhsplan.pdf. Accessed July 1, 2000.
2. Professor the Lord Darzi of Denham KBE. High quality care for all. NHS next stage review. Final report. Department of Health. June 30, 2008. Available at: http://www.sdh.gov.uk/en/publicationsandstatistics/ publications/ publicationspolicyand guidance/dh-085825. Accessed June 30, 2008.
3. Russo T. UK healthcare reimbursement. A market research report from the U.S. commercial service. 2005. Available at: http://commercecan.ic.gc.ca/scdt/ bizmap/interface2.nsf/vdownload/ ISA-2805/$file/X-8252893.doc. Accessed July 2, 2005.
4. NHS National Services Scotland Annual Report 2006-2007. Available at: http://www.nhsnss.org/uploads/publications/ nss-annual-report0607.pdf. Accessed February 4, 2008.
5. NHS Wales Annual Report 2006-2007. Available at: http://www.wales.nhs.uk/ sites3/Documents/92/ Annual%5FReport%5F2006.2007.pdf. Accessed January 10, 2008.
6. Selling to the NHS. A guide to suppliers. NHS Purchasing and Supply Agency. Available at: http://www.pasa.nhs.uk/PASAWeb/ Supplierzone/ SellingtotheNHS/. Accessed November 26, 2007.
7. Department of Health. NHS Payment by Results Guidance 2008/09. December 2007. Available at: http://www.dh.gov.uk/en/ publicationsandstatistics/ publication/publicationspolicyandguidance/ dh-081096. Accessed December 14, 2007.
8. Department of Health Consultation. Options for the future of payment by results: 2008/09 to 2010/11. March 15, 2007. Available at: http://www.dh.gov.uk/ En/consultations/liveconsulatations/dh-073103. Accessed March 15, 2007.
9. Department of Health. Healthcare Industry Task Force. Better health through partnership: a programme for action. November 17, 2004. Available at: http://www.dh.gov.uk/en/publicationsandstatistics/ publications/ publicationspolicyandguidance/dh-4094982. Accessed November 17, 2004.
10. Creed GM. Point of care testing in the United Kingdom. Crit Care Nurs Q. 2001;24:44-48.
11. Ali T, Scrafton J, Andrews R. Near patient testing for cardiac troponin I to reduce hospital stay in patients presenting with chest pain. Br J Cardiol (Acute Interv Cardiol). 2006;13:19-21.
12. Males RG, Stephenson J, Harris P. Cardiac markers and point of care testing: a perfect fit. Crit Care Nurs Q. 2001;24:54-61.
13. Hamilton AJ, Swales LA, Neill J, et al. Risk stratification of chest pain patients in the emergency department by a nurse utilising a point of care protocol. Eur J Emerg Med. 2008;15:9-15.
14. Dunn F, Hughes D, Rocke LGR, et al. Are chest pain observation units essential for rapid and effective emergency care in the UK? Emerg Med J. 2006;23:487-493.
15. Frost & Sullivan. Market engineering research for the UK acute cardiac diagnostics markets. Forecast for the UK total acute diagnostics market. No.B549-55. Frost & Sullivan Web site. August 1, 2005. Available at http://www.healthcare.frost.com. Accessed August 1, 2005.
16. Ming Ng S, Krishnaswamy P, Morissey R, et al. Ninety minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001;88:611-617.
17. Lee-Lewandrowski E, Benzer T, Corboy D, et al. Cardiac marker testing as part of an emergency department point-of-care satellite laboratory in a large academic medical center. Practical issues concerning implementation. Point of Care. 2002;1(3):145-154.
18. Wu AHB. Point-of-care testing for conventional cardiac markers. Point of Care. 2006;5(1):20-24.
19. Boufous S, Kelleher PW, Pain CH, et al. Impact of a chest-pain guideline on clinical decision making. MJA. 2003;178:375-380.
20. Goodacre S, Locker T, Arnold J, et al. Which diagnostic tests are most useful in a chest pain unit protocol? BMC Emerg Med. 2005;5:1-7.
21. Price CP. Medical and economic outcomes of point of care testing. Clin Chem Lab Med. 2002;40:246-251.
22. Price CP. Delivering clinical outcomes.Point of Care. 2003;2(3):151-157.
23. Fox KF. Investigation and management of chest pain. Heart. 2005;91:105-110.
24. Dougan JP, Mathew TP, Riddell JW, et al. Suspected angina pectoris: a rapid-access chest pain clinic. Q J Med. 2001;94:679-686.
25. Kost JK, Tran NK. Point of care testing and cardiac biomarkers: the standard of care and vision for chest pain centres. Cardiol Clin. 2005;23:467-490.
26. Price CP. Point of care testing. BMJ. 2001;322:1285-1288.
27. Giuliano K, Grant ME. Blood analysis at the point of care: issues in application for use in critically ill patients. Point of Care. 2002;13(2):204-220.
28. Huckle D. Point-of-care diagnostics: will the hurdles be overcome this time? Expert Rev Med Devices. 2006;3(4):421-426.
29. Burnell S. Addressing country differences in the point of care diagnostic market. A European focus. Cambridge Consultants Web site. Available at: http://www.cambridgeconsultants.com/downloads/library/ POC-European-focus.pdf. Accessed May 16, 2008.
30. Huckle D. Point-of-care diagnostics: an advancing sector with non-technical issues. Expert Rev Mol Diagn. 2008;8(6):679-688.
31. Independent Review of NHS Pathology Services. Response from Industry. BIVDA. January 27, 2006. Available at: http:// www.bivda.co.uk/Portals/0/ Path%20review%20BIVDA% 20response%2027Jan06vs2.doc.
32. Charny M. Reimbursement for point-of-care diagnostics opportunities and barriers. Market Access for Point-of-Care Diagnostics Conference, Amsterdam, May 13-14, 2008. Available at: http:// www.informa-ls.com/POCT/docs. Accessed May 20, 2008.
33. Pearson J. Point-of-care testing and clinical governance. Clin Chem Lab Med. 2006;44(6):765-767.
34. Pearson J Establishing the clinical utility of POCT. Market Access for Point-of-Care Diagnostics Conference, Amsterdam, May 13-14, 2008. Available at: http://www.informa-ls.com/POCT/docs. Accessed May 20, 2008.
35. FitzGibbon F, Meenan BJ, Brown A, et al. User perspectives of cardiac marker point-of-care testing for hospital based chest pain diagnosis. Point of Care. 2008;7(2):1-7.
36. Martin CL. Quality control issues in point of care testing. Clin Biochem Rev. 2008;29(suppl(i)):79-82.
37. Price CP. Point of care testing for cardiac markers: applications and outcomes. Point of Care. 2008;7(4):261-265.
38. Thomas MA. Quality assurance and accreditation in point of care testing. Point of Care. 2008;7(4):227-232.
39. Burnell S. The future of diagnostics: are labs vital? Diagnostics report 2009. Cambridge Consultants Web site. Available at: http:// www. cambridgeconsultants.com/fm-diagnostics-08.html. Accessed March 2009.
40. Ehrmeyer SS, Laessig RH. Point of care testing: implementation and practice of cost effective total quality management. Accredit Qual Assur. 1999;4(419):422.
41. Department of Health. Report of the Review of the NHS Pathology Services in England 2006. Available at: http://www. thecarterreview.com/downloads/ CarterReview PathologyReport.pdf. Accessed August 2, 2006.
42. Department of Health, Social services and Public Safety. Recommendations for the future of pathology services in Northern Ireland. Department of Health, Social Services and Public Safety Web site. December 27, 2007. Available at: http://www.dhsspsni.gov.uk/ pathology-review-final-recommendations-document.pdf. Accessed December 27, 2007.
43. Department of Health, Social Services and Public Safety. The future of pathology services in Northern Ireland. Department of Health, Social Services and Public Safety Web site. November 2006. Available at: http://www.dhsspsni. gov.uk/ full-review-document-(pdf-1.40-mb).pdf. Accessed November 28, 2006.
44. Beastall GH. The modernisation of pathology and laboratory medicine in the UK: networking into the future. Clin Biochem Rev. 2008;29:3-10.
45. Centre for Evidence-Based Purchasing, NHS Purchasing and Supply Agency (PASA) evaluation report. Three point of care devices for troponin measurement. PASAWeb site. May 2006. Available at: http:// www.pasa.nhs.uk/pasa/Doc.aspx? Path=[MN][SP]/NHSprocurement/ CEP/poc/Report%2006020.pdf. Accessed May 2008.
46. Central Services Agency. Regional Supplies Service. A Short Guide to the Regional Supplies Service (RSS) and the Procurement Process for the Northern Ireland Health and Personal Social Services (HPSS). Belfast: Central Services Agency; 2005.
47. Supplies Procurement Follow-up in Northern Ireland Regional Summary. Performance Review Unit. Department of Health, Social Services and Public Safety (DHSSPNI). Available at: http://www.dhsspsni.gov.uk/supplies-procurement- followup- in-northern-ireland-regional-summary.pdf. Accessed April 2, 2002.
48. Molloy T. NI Health & Social Care Procurement. Past, present and future. All Island Procurement Conference and Exhibition, Dublin, Ireland, May 1-2, 2007. Available at: http://www.allislandppc.com/images/site/assets/ Teresa%20Molloy%20presentation%20Day%202.ppt. Accessed May 4, 2007.
49. Scott M, Mairs J. Pharmaceutical procurement in Northern Ireland. All Island Procurement Conference and Exhibition, Dublin, Ireland, May 1-2, 2007. Available at: http://www.allislandppc.com/images/site/ assets/ Jill%20Mairs%20and%20M%20Scott%20presentation.ppt. Accessed May 4, 2007.
50. Galloway M. Making sense of the pathology tariffVhow will it work in practice? Health Service Journal Pathology Modernisation Conference, London, UK, June 19, 2008. Available at: http://www.hsj-pathology.co.uk/homepage.asp. Accessed June 19, 2008.
51. Woolf SH, Henshall C. Health technology assessment in the United Kingdom. Int J Technol Assess Health Care. 2000;16(2):591-625.
52. Wild C, Langer T. Emerging health technologies: informing and supporting health policy early. Health Policy. 2008;87(2):160-171.
53. NHS National Institute for Health and Clinical Excellence. A guide to NICE, 2005. Available at: http://www.nice.org.uk/ nicemedia/pdf/ NewguidetoNICEApril2005.pdf. Accessed April 2, 2005.
54. Craig J, Bradbury I, Collinson P, et al. The organisation of troponin testing services in acute coronary syndromes. Health Technology Assessment Report 4. Glasgow: NHS Quality Improvement Scotland; 2004. Available at: http://nhsqualityimprovementscotland.org/nhsqis/ files/ troponinconsultationreport.pdf. Accessed July 27, 2004.
55. Guidelines and Audit Implementation Network (GAIN). Department of Health, Social Services and Public Safety, Northern Ireland. 2008. Available at: http://www.dhsspsni.gov.uk/index/hss/gain.htm. Accessed March 1, 2010.
56. FitzGibbon F. Multidisciplinary Assessment of Technology Assessment Centre for Healthcare (MATCH) Programme at the University of Ulster conducts a survey of lab-on-chip point-of-care device manufacturers. BiochipNet News. November/December 2-3, 2007. Available at: http://www.biochipnet.com/files/ November-2007.pdf. Accessed November 1, 2007.
57. Craven M. The MATCH project: collaboration between academia and industry. ABHI Focus Mag. 2004;15-16.
58. Johal SS, Oliver P, Williams HC. Better decision-making for evaluating new medical device projectsVa real options approach. J Med Marketing. 2008;8(2):101-112.
59. Steuten L, Vallejo-Torres L, Young T, et al. Transferability of economic evaluations of medical technologiesVexemplar of a new technology used in orthopaedic surgery. Expert Rev Med Devices. 2008;5(3):329-336.
60. Brown A, Meenan BJ, Young TP. Medical device prices follow the experience curve. J Med Market. 2007;7(3):203-212.
61. Apple FS, Murakami MA, Christenson RH, et al. Analytical performance of the i-Stat cardiac troponin I assay. Clin Chim Acta. 2004;345:123-127.
62. Clark TJ, McPherson PH, Buechler KF. The Triage cardiac panel. Cardiac markers for the Triage system. Point of Care. 2002;1(1):42-46.
63. Bauer R, Cheryk L, Thompson T, et al. Stratus CS Stat fluorometric analyser. Point of Care. 2002;1(1):54-57.
64. Wu AHB, Smith A, Christenson RH, et al. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta. 2004;346:21-219.
65. Nichols JH. Point of care testing. Clin Lab Med. 2007;27:893-908.
66. Othman YH, Remsh EA, Al-Katani A, et al. How to manage successful point of care testing program. Point of Care. 2008;7(4):239-242.
67. Kost GJ. The millennium challenge for point-of-care testing. Arch Pathol Lab Med. 2000;124:1108-1110.
68. Pietzsch JB, Paté-Cornell ME. Early technology assessment of new medical devices. Int J Technol Assess Health Care. 2008;24(1):36-44.
69. Lord Carter of Coles. Department of Health. Report of the second phase of the review of NHS Pathology Services in England. 18 December 2008. Department of Health Web site. Available at: http://www.dh.gov.gov.uk/en/ publicationsandstatistics/publications/ publicationspolicyandguidance/dh-091984. pdf. Accessed December 18, 2008.
70. Department of Health. The Department of Health's response to the report of the second phase of the independent review of NHS Pathology Services in England. Department of Health Web site. Available at: http://www.dh.gov.uk/ publicationsandstatistics/ publications/publicationspolicyandguidance/dh-091983. pdf. Accessed December 18, 2008.
71. Rainey PM. Outcomes assessment for point of care testing. Clin Chem. 1998;44:1595-1596.
72. FitzGibbon F, Meenan BJ, Huckle D, et al. Perspectives on the impact of point-of-care testing for cardiac markers on healthcare professional working relationships. Acute Care Testing Web site. Available at: http://www. acutecaretesting.org. Accessed April 2009.